Clinical trial
Prospective Evaluation of Hypoxia in Primary Melanoma
NCT06831071 is registered in ClinicalTrials.gov with Yana Najjar as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective Evaluation of Hypoxia in Primary Melanoma
- Lead sponsor
- Yana Najjar
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- April 9, 2025
- Completion date
- March 31, 2029
- Enrollment
- 50 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.